FORSYTHIA SUSPENSA FRUIT

Manufacturer
Chunwoo Pharmaceutical Co., Ltd.
Effective date
2022-01-31
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 02:15:41

Label at a glance#

ProductCebashin Cap.
Active ingredientFORSYTHIA SUSPENSA FRUIT, LICORICE, PLATYCODON GRANDIFLORUS ROOT, ARCTIUM LAPPA FRUIT, LONICERA JAPONICA WHOLE, MENTHA ARVENSIS TOP, GLYCINE MAX WHOLE, SCHIZONEPETA TENUFOLIA SPIKE, LOPHATHERUM GRACILE TOP, SAIGA TATARICA HORN
Label structure8 sections

Indications and uses

a sore throat, thirst, cough, headache from a cold

Dosage and administration

For adults, take 1 packet per intake, 3 times a day, before or between meals

Label contents#

Full prescribing information#

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

FORSYTHIA SUSPENSA FRUIT }

LONICERA JAPONICA WHOLE }

MENTHA ARVENSIS TOP }

PLATYCODON GRANDIFLORUS ROOT }

LICORICE }

ARCTIUM LAPPA FRUIT } ----------------------------------------- cold / cough aid

GLYCINE MAX WHOLE }

LOPHATHERUM GRACILE TOP }

SCHIZONEPETA TENUFOLIA SPIKE }

SAIGA TATARICA HORN }

Purpose

OTC - PURPOSE SECTION

Cold/cough aid

Directions

DOSAGE & ADMINISTRATION SECTION

For adults, take 1 packet per intake, 3 times a day, before or between meals

Inactive ingredients

INACTIVE INGREDIENT SECTION

Corn Starch, Animal originated ingredients: Lactose Hydrate/Cow Milk

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Warnings

WARNINGS SECTION

Do not use if you are

  • Children under 5 years old

Do not use if you have

  • Galactose intolerance
  • Lapp lactase deficiency
  • Glucose-galactose malabsorption (this medicine contains lactose)

Ask a doctor before use if you

  • have hypertension
  • have a heart disease or a kidney disease
  • a patient with edema
  • pregnant or have a chance to pregnant
  • a patient who has rashes, bloodshot, redness, itching, and etc. caused by medication
  • a patient with significantly weakened stomachs
  • an elderly person (in general, elderly people should take with care, such as reducing their dosage, as their physiological function has deteriorated)
  • in a post-disease stage (am abnormal reaction can be easily seen and the symptoms can worsen)
  • a patient who is being treated by a doctor or are taking other medications

Stop use and ask a doctor, pharmacist or health professionals if

  • if there is no improvement in symptoms after taking it for a few days
  • you have following symptoms after use:

- Pseudohyperaldosteronism: Reduced urine volume, swollen face, swollen hands and feet, heavy eyelids, firm hands, increased blood pressure, headache, and etc. (Mediciness with a maximum daily dose of 1g or more may develop hypoglycemia, blood pressure rise, low sodium body fluid, edema, weight gain, and etc. caused by pseydohyperaldosteronism if taken continuously for a long time. Therefore, make sufficient observations (measurement of serum potassium levels) and stop taking if there is any abnormality.)

-Myopathy: Myopathy (muscle disease) may occur as a result of hypokalemia, so take sufficient observation and stop taking if you find any abnormalities such as feeling helplessness, limb cramps, paralysis, and etc.

-Skin trouble: a rash, itch, bloodshot, and etc.

-Digestive system disorder: anorexia, stomach discomfort, nausea, vomiting, and etc.

Other Warnings

  • do not take more than directed
  • if children are to take this medicine, take it under the supervision of their guardian.
  • when taken with potassium-containing agents, licorice-containing agents, glycirizinic acid or other related agents, loop diuretics (furosemide, ethacrynic acid), or thiazide diuretics (trichlormethiazide) and myopathy, it is likely to appear due to gastric aldosterone (pseudohyperaldosteronism) or hypokalemia
  • If taken with other herbal medicines, be careful of overlapping of the crude medicines.
  • In principle, you should not to take it continuously for a long time, but if it is necessary, consult with a doctor, herb doctor, dentist, pharmacist, or other health care professionals.

Uses

INDICATIONS & USAGE SECTION

a sore throat, thirst, cough, headache from a cold

Cebashin Cap.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

cebashincebashin

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72850-0007-22024-01-30C16284748780-11030e365-57a1-111a-e063-dadaa90a10e2Cebashin Cap.

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72850-0007-1Cebashin Cap.10 g in 1 CAPSULECAPSULE102
72850-0007-2Cebashin Cap.1 in 1 BOXCAPSULE12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72850-0007CEBASHIN CAP. (FORSYTHIA SUSPENSA FRUIT, LONICERA JAPONICA WHOLE, MENTHA ARVENSIS TOP, PLATYCODON GRANDIFLORUS ROOT, LICORICE, ARCTIUM LAPPA FRUIT, GLYCINE MAX WHOLE, LOPHATHERUM GRACILE TOP, SCHIZONEPETA TENUFOLIA SPIKE, SAIGA TATARICA HORN) CAPSULE [CHUNWOO PHARMACEUTICAL CO., LTD.]2Legacy NDC, 2 package rows20220201_d3c1a869-be57-38a4-e053-2995a90a0d62.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72850-000772850-0007-1, 72850-0007-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d6e992e3-5ca4-17fe-e053-2a95a90ae31bd3c1a869-be57-38a4-e053-2995a90a0d622022-01-31WarningsExact identifier
spl id: d6e992e3-5ca4-17fe-e053-2a95a90ae31b
spl set id: d3c1a869-be57-38a4-e053-2995a90a0d62

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.